These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24353191)

  • 1. A population study of urine glycerol concentrations in elite athletes competing in North America.
    Kelly BN; Madsen M; Sharpe K; Nair V; Eichner D
    Drug Test Anal; 2013; 5(11-12):890-5. PubMed ID: 24353191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of urinary glycerol levels for doping control purposes using gas chromatography-mass spectrometry.
    Thevis M; Guddat S; Flenker U; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):117-25. PubMed ID: 18708691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of analytical finding of glycerol caused by self-catheterization in doping control.
    Okano M; Nishitani Y; Kageyama S
    Drug Test Anal; 2014; 6(11-12):1151-4. PubMed ID: 25079056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of glycerol: colourimetric screening and gas chromatography-mass spectrometric confirmation.
    Sardela VF; Scalco FB; Cavalcante KM; Simoni RE; Silva DR; Pereira HM; de Oliveira ML; Aquino Neto FR
    Drug Test Anal; 2015 Oct; 7(10):967-70. PubMed ID: 26112364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances.
    Del Coso J; Muñoz G; Muñoz-Guerra J
    Appl Physiol Nutr Metab; 2011 Aug; 36(4):555-61. PubMed ID: 21854160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine Caffeine Concentration in Doping Control Samples from 2004 to 2015.
    Aguilar-Navarro M; Muñoz G; Salinero JJ; Muñoz-Guerra J; Fernández-Álvarez M; Plata MDM; Del Coso J
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30699902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of dehydroepiandrosterone misuse by means of gas chromatography- combustion-isotope ratio mass spectrometry.
    Mareck U; Geyer H; Flenker U; Piper T; Thevis M; Schänzer W
    Eur J Mass Spectrom (Chichester); 2007; 13(6):419-26. PubMed ID: 18417762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine analysis concerning xenon for doping control purposes.
    Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of glycerol levels in human urine by liquid chromatography-tandem mass spectrometry.
    Dong Y; Ma Y; Yan K; Shen L; Wang X; Xu Y; He G; Wu Y; Lu J; Yang Z; Feng F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():30-5. PubMed ID: 24657408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes.
    Hostrup M; Kalsen A; Auchenberg M; Rzeppa S; Hemmersbach P; Bangsbo J; Backer V
    Drug Test Anal; 2014 Jun; 6(6):528-32. PubMed ID: 24166762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying cobalt in doping control urine samples--a pilot study.
    Krug O; Kutscher D; Piper T; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1186-90. PubMed ID: 25044557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration.
    Jarek A; Wójtowicz M; Kwiatkowska D; Kita M; Turek-Lepa E; Chajewska K; Lewandowska-Pachecka S; Pokrywka A
    Drug Test Anal; 2014; 6(11-12):1191-6. PubMed ID: 25421604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N,N-dimethyl-2-phenylpropan-1-amine - new designer agent found in athlete urine and nutritional supplement.
    Kwiatkowska D; Wójtowicz M; Jarek A; Goebel C; Chajewska K; Turek-Lepa E; Pokrywka A; Kazlauskas R
    Drug Test Anal; 2015 Apr; 7(4):331-5. PubMed ID: 25355281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of urinary AICAR concentrations as a matter of doping controls.
    Thomas A; Beuck S; Eickhoff JC; Guddat S; Krug O; Kamber M; Schänzer W; Thevis M
    Anal Bioanal Chem; 2010 Apr; 396(8):2899-908. PubMed ID: 20225061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
    Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
    Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control.
    Brooker L; Parr MK; Cawley A; Flenker U; Howe C; Kazlauskas R; Schänzer W; George A
    Drug Test Anal; 2009 Nov; 1(11-12):587-95. PubMed ID: 20355175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples.
    Walpurgis K; Scheiff AB; Welz M; Müller-Reul J; Webborn N; Görgens C; Guddat S; Fußhöller G; Dib J; Thevis M
    Drug Test Anal; 2019 Nov; 11(11-12):1755-1760. PubMed ID: 31670462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enigma of inhaled salbutamol and sport: unresolved after 45 years.
    Fitch KD
    Drug Test Anal; 2017 Jul; 9(7):977-982. PubMed ID: 28294577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
    Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
    Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.